FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells

Sphingosine kinase 1 (SK1) is an enzyme that catalyses the phosphorylation of sphingosine to produce the bioactive lipid sphingosine 1-phosphate (S1P). We demonstrate here that FTY720 (Fingolimod™) and (S)-FTY720 vinylphosphonate are novel inhibitors of SK1 catalytic activity and induce the proteasomal degradation of this enzyme in human pulmonary artery smooth muscle cells, MCF-7 breast cancer cells and androgen-independent LNCaP-AI prostate cancer cells. Proteasomal degradation of SK1 in response to FTY720 and (S)-FTY720 vinylphosphonate is associated with the down-regulation of the androgen receptor in LNCaP-AI cells. (S)-FTY720 vinylphosphonate also induces the apoptosis of these cells. These findings indicate that SK1 is involved in protecting LNCaP-AI from apoptosis. This protection might be mediated by so-called ‘inside-out’ signalling by S1P, as LNCaP-AI cells exhibit increased expression of S1P2/3 receptors and reduced lipid phosphate phosphatase expression (compared with androgen-sensitive LNCaP cells) thereby potentially increasing the bioavailability of S1P at S1P2/3 receptors.

• Publication year

  2010

• Venue

  Cellular Signalling

• Publication date

  2010-10-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.cellsig.2010.05.022PMID 20570726PMCID 2947314
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FTY720 Inhibits Ceramide Synthases and Up-regulates Dihydrosphingosine 1-Phosphate Formation in Human Lung Endothelial Cells*

  2009cited by this paper
• Kinetics and kinematics for translational motions in microgravity during parabolic flight.

  2009cited by this paper
• Ceramide Synthesis Is Modulated by the Sphingosine Analog FTY720 via a Mixture of Uncompetitive and Noncompetitive Inhibition in an Acyl-CoA Chain Length-de pend ent Manner*

  2009cited by this paper
• Chiral vinylphosphonate and phosphonate analogues of the immunosuppressive agent FTY720.

  2009cited by this paper
• Lung Tumor Development in the Presence of Sphingosine 1-phosphate Agonist FTY720

  2009cited by this paper
• “Inside-Out” Signaling of Sphingosine-1-Phosphate: Therapeutic Targets

  2008cited by this paper
• Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cells.

  2008cited by this paper
• FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma.

  2008cited by this paper
• FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling.

  2008cited by this paper
• Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models

  2008cited by this paper
• Dimethylsphingosine and FTY720 inhibit the SK1 form but activate the SK2 form of sphingosine kinase from rat heart

  2007cited by this paper
• FTY720, a synthetic compound from Isaria sinclairii, inhibits proliferation and induces apoptosis in pancreatic cancer cells.

  2007cited by this paper
• FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft.

  2007cited by this paper
• The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors.

  2007cited by this paper
• Marked suppression of tumor growth by FTY720 in a rat liver tumor model: the significance of down-regulation of cell survival Akt pathway.

  2007cited by this paper
• FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.

  2007cited by this paper
• High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation.

  2006cited by this paper
• Enantioselective synthesis of the phosphate esters of the immunosuppressive lipid FTY720

  2006cited by this paper
• Mouse Sphingosine Kinase Isoforms SPHK1a and SPHK1b Differ in Enzymatic Traits Including Stability, Localization, Modification, and Oligomerization*

  2006cited by this paper
• Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization.

  2006cited by this paper
• Histamine increases sphingosine kinase-1 expression and activity in the human arterial endothelial cell line EA.hy 926 by a PKC-alpha-dependent mechanism.

  2006cited by this paper
• Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models.

  2005cited by this paper
• FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance.

  2005cited by this paper
• Involvement of the Ubiquitin-Mediated Proteolytic System in the Signaling Pathway Induced by Ceramide in Primary Astrocyte Cultures

  2005cited by this paper
• The Immune Modulator FTY720 Inhibits Sphingosine-1-phosphate Lyase Activity*

  2005cited by this paper
• FTY720, a fungus metabolite, inhibits invasion ability of androgen-independent prostate cancer cells through inactivation of RhoA-GTPase.

  2005cited by this paper
• Sphingosine Kinase 1 Is an Intracellular Effector of Phosphatidic Acid*

  2004cited by this paper
• The immunosuppressant FTY720 down‐regulates sphingosine 1‐phosphate G protein‐coupled receptors

  2004cited by this paper
• Lysophosphatidic acid and sphingosine 1-phosphate biology: the role of lipid phosphate phosphatases.

  2004cited by this paper
• A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells

  2003cited by this paper
• Selective cancer cell apoptosis induced by FTY720; evidence for a Bcl-dependent pathway and impairment in ERK activity.

  2003cited by this paper
• Discovery and evaluation of inhibitors of human sphingosine kinase.

  2003cited by this paper
• Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development

  2003cited by this paper
• Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment.

  2003cited by this paper
• Phosphorylation and Action of the Immunomodulator FTY720 Inhibits Vascular Endothelial Cell Growth Factor-induced Vascular Permeability*

  2003cited by this paper
• Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

  2002cited by this paper
• The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors*

  2002cited by this paper
• Tethering of the platelet-derived growth factor beta receptor to G-protein-coupled receptors. A novel platform for integrative signaling by these receptor classes in mammalian cells.

  2001cited by this paper
• Sphingosine 1-phosphate signalling in mammalian cells

  2000cited by this paper
• Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells.

  2000cited by this paper
• Molecular Cloning and Functional Characterization of a Novel Mammalian Sphingosine Kinase Type 2 Isoform*

  2000cited by this paper
• Sphingosine 1-phosphate signalling in mammalian cells.

  2000cited by this paper
• Early induction of apoptosis in androgen‐independent prostate cancer cell line by FTY720 requires caspase‐3 activation

  1999cited by this paper
• Molecular Cloning and Functional Characterization of Murine Sphingosine Kinase*

  1998cited by this paper
• Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis

  1994cited by this paper

• Potential of SPHK1 as a prognostic marker and therapeutic target in colorectal cancer: insights from bioinformatics and experimental analysis.

  2025cites this paper
• Transition metal-catalyzed P(O)–H alkenylation, allenylation and alkynylation reactions: A recent trend

  2025cites this paper
• Thin Layer Chromatography Goes Ultrasmall to Assay Sphingosine Kinase Activation in Single Primary Leukemic Cells.

  2025cites this paper
• Pathway analysis of peripheral blood CD8+ T cell transcriptome shows differential regulation of sphingolipid signaling in multiple sclerosis and glioblastoma

  2024cites this paper
• Multiple sclerosis and cancer: Navigating a dual diagnosis

  2024cites this paper
• Pharmacological Effects of FTY720 and its Derivatives.

  2024cites this paper
• Sphingosine kinase 1/S1P receptor signaling axis is essential for cellular uptake of Neisseria meningitidis in brain endothelial cells

  2023cites this paper
• Small-molecule agents for cancer immunotherapy

  2023cites this paper
• Copper-catalyzed 4-HO-TEMPOH mediated phosphorylation of alkenes.

  2023cites this paper
• Targeting Sphingosine 1-Phosphate Metabolism as a Therapeutic Avenue for Prostate Cancer

  2023cites this paper
• Prognosis-related metabolic genes in the development of colorectal cancer progress and perspective.

  2023cites this paper
• Emerging Roles of Ceramides in Breast Cancer Biology and Therapy

  2022cites this paper
• Chicoric acid ameliorates palmitate-induced sphingosine 1-phosphate signaling pathway in the PBMCs of patients with newly diagnosed type 2 diabetes

  2022cites this paper
• Molecular Pharmacology and Novel Potential Therapeutic Applications of Fingolimod

  2022cites this paper
• Expression Profile of Sphingosine Kinase 1 Isoforms in Human Cancer Tissues and Cells: Importance and Clinical Relevance of the Neglected 1b-Isoform

  2022cites this paper
• Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy

  2021cites this paper
• Plasma Sphingosine-1-Phosphate Levels Are Associated with Progression of Estrogen Receptor-Positive Breast Cancer

  2021cites this paper
• Increased Sphingosine-1-Phosphate Serum Concentrations in Subjects with Periodontitis: A Matter of Inflammation

  2021cites this paper
• Sphingosine Kinase 1 Signaling in Breast Cancer: A Potential Target to Tackle Breast Cancer Stem Cells

  2021cites this paper
• FTY720 Inhibits Expansion of Breast Cancer Stem Cells via PP2A Activation

  2021cites this paper
• Selenium nanoparticles coated with pH responsive silk fibroin complex for fingolimod release and enhanced targeting in thyroid cancer

  2021cites this paper
• Ceramide Metabolism Enzymes—Therapeutic Targets against Cancer

  2021cites this paper
• Erythrocyte sphingosine kinase regulates intraerythrocytic development of Plasmodium falciparum

  2021cites this paper
• Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer

  2021cites this paper
• The Therapeutic Targets of Fingolimod (FTY720) Are Involved in Pathological Processes in the Frontal Cortex of Alzheimer's Disease Patients: A Network Pharmacology Study

  2021cites this paper
• Targeting Sphingolipids for Cancer Therapy

  2021cites this paper
• Bioactive sphingolipids: Advancements and contributions from the laboratory of Dr. Lina M. Obeid

  2020cites this paper
• Analysis of selective target engagement by small-molecule sphingosine kinase inhibitors using the Cellular Thermal Shift Assay (CETSA)

  2020cites this paper
• Sphingosine Kinases are Involved in Macrophage NLRP3 Inflammasome Transcriptional Induction

  2020cites this paper
• Synergic effect of OP449 and FTY720 on oral squamous cell carcinoma.

  2020cites this paper
• Sphingosine Kinase 1 in Breast Cancer—A New Molecular Marker and a Therapy Target

  2020cites this paper
• Design and Development of Novel Urea, Sulfonyltriurea, and Sulfonamide Derivatives as Potential Inhibitors of Sphingosine Kinase 1

  2020cites this paper
• Verification of the Necessity of the Tolyl Group of PF-543 for Sphingosine Kinase 1 Inhibitory Activity

  2020cites this paper
• Sphingosine Kinase 1 Regulates the Survival of Breast Cancer Stem Cells and Non-stem Breast Cancer Cells by Suppression of STAT1

  2020cites this paper
• Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies

  2020cites this paper
• In vitro anticancer evaluation of micelles containing N-(4-(2-((4-methoxybenzyl)amino)ethyl)phenyl)heptanamide, an analogue of fingolimod

  2020cites this paper
• Structure-function analysis of lipid substrates and inhibitors of sphingosine kinases.

  2020cites this paper
• Inhibition of Sphingosine-1-Phosphate signaling in pancreatic ductal adenocarcinoma leads to downregulation of growth and invasion

  2020cites this paper
• Recent advances in the role of sphingosine 1‐phosphate in cancer

  2020cites this paper
• Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities

  2020cites this paper
• Design of Sphingosine Kinases Inhibitors: Challenges and Recent Developments.

  2019cites this paper
• Beneficial Effects of Fingolimod in Alzheimer’s Disease: Molecular Mechanisms and Therapeutic Potential

  2019cites this paper
• Synthesis and Biological Evaluation of PF-543 Derivative Containing Aliphatic Side Chain.

  2019cites this paper
• FTY720 induces non-canonical phosphatidylserine externalization and cell death in acute myeloid leukemia

  2019cites this paper
• MCT-17-1141 289..300

  2019cites this paper
• Effect of the sphingosine kinase 1 selective inhibitor, on arterial and cardiac remodeling in a hypoxic model of pulmonary arterial hypertension. Signalling,

  2019cites this paper
• Short Periods of Hypoxia Upregulate Sphingosine Kinase 1 and Increase Vasodilation of Arteries to Sphingosine 1-Phosphate (S1P) via S1P3

  2019cites this paper
• Cytokine‐Induced and Stretch‐Induced Sphingosine 1‐Phosphate Production by Enthesis Cells Could Favor Abnormal Ossification in Spondyloarthritis

  2019cites this paper
• Kelch-like protein 5-mediated ubiquitination of lysine 183 promotes proteasomal degradation of sphingosine kinase 1.

  2019cites this paper
• Requirement for sphingosine kinase 1 in mediating phase 1 of the hypotensive response to anandamide in the anaesthetised mouse

  2019cites this paper
• SPHINGOSINE KINASE 1 REGULATES FASCIN EXPRESSION TO PROMOTE METASTASIS IN TRIPLE NEGATIVE BREAST CANCER

  2018cites this paper
• Molecular mechanisms of regulation of sphingosine kinase 1.

  2018cites this paper
• Sphingosine kinase 1 overexpression contributes to sunitinib resistance in clear cell renal cell carcinoma

  2018cites this paper
• Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas

  2018cites this paper
• Synthesis of Novel FTY720 Analogs with Anticancer Activity through PP2A Activation

  2018cites this paper
• Synergistic effects of vemurafenib and fingolimod (FTY720) in vemurafenib‑resistant melanoma cell lines.

  2018cites this paper
• Sphingolipid metabolism and drug resistance in ovarian cancer

  2018cites this paper
• PP2A deactivation is a common event in oral cancer and reactivation by FTY720 shows promising therapeutic potential

  2018cites this paper
• Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors

  2018cites this paper
• tigated the effects of FTY720 and vemurafenib combination treatment on cell death induction, and defined the molecular mechanisms in vemurafenib-resistant melanoma cells. The combination treatment with FTY720 and vemurafenib reduced cell viability, and the expression of apoptosis-associated cleaved

  2018influential citation
• Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis.

  2018cites this paper
• Regio- and Stereoselective Hydrophosphorylation of Ynamides for the Synthesis of β-Aminovinylphosphine Oxides.

  2018cites this paper
• Targeting sphingosine-1-phosphate signaling for cancer therapy

  2017cites this paper
• Sphingosine‐1‐phosphate modulators in inflammatory skin diseases – lining up for clinical translation

  2017cites this paper
• On the role of bioactive sphingolipids and their metabolizing enzymes in cancer

  2017cites this paper
• The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives.

  2017cites this paper
• Sphingosine Kinase 1: A Potential Therapeutic Target in Pulmonary Arterial Hypertension?

  2017influential citation
• Effect of hypoxia on the cardiovascular sphingolipid system

  2017cites this paper
• Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget

  2017cites this paper
• A Phosphorylatable Sphingosine Analog Induces Airway Smooth Muscle Cytostasis and Reverses Airway Hyperresponsiveness in Experimental Asthma

  2017cites this paper
• Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade

  2017cites this paper
• “Dicing and Splicing” Sphingosine Kinase and Relevance to Cancer

  2017cites this paper
• Effect of sphingosine kinase modulators on interleukin‐1β release, sphingosine 1‐phosphate receptor 1 expression and experimental autoimmune encephalomyelitis

  2017cites this paper
• Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism

  2017cites this paper
• Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System

  2017cites this paper
• 1 ROLE OF SPHINGOSINE 1-PHOSPHATE RECEPTORS , SPHINGOSINE KINASES AND SPHINGOSINE IN CANCER AND INFLAMMATION

  2017influential citation
• Sphingosine 1-phosphate and cancer.

  2017cites this paper
• Rh(I)‐Catalyzed Arylation of α‐Diazo Phosphonates with Aryl Boronic Acids: Synthesis of Diarylmethylphosphonates

  2017cites this paper
• FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model

  2017cites this paper
• Sphingosine 1-Phosphate Activation of EGFR As a Novel Target for Meningitic Escherichia coli Penetration of the Blood-Brain Barrier

  2016cites this paper
• Biological Effects of Naturally Occurring Sphingolipids, Uncommon Variants, and Their Analogs

  2016cites this paper
• FTY720 (Fingolimod) attenuates basal and sphingosine-1-phosphate-evoked thyroid cancer cell invasion.

  2016influential citation
• Cigarette smoke inhibits efferocytosis via deregulation of sphingosine kinase signaling: reversal with exogenous S1P and the S1P analogue FTY720

  2016cites this paper
• The emerging role of FTY720 (Fingolimod) in cancer treatment

  2016influential citation
• Recent advances in the development of sphingosine kinase inhibitors.

  2016cites this paper
• Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies

  2016cites this paper
• Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension

  2016cites this paper
• Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells

  2016cites this paper
• Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation.

  2016cites this paper
• Topical Application of Fingolimod Perturbs Cutaneous Inflammation

  2016cites this paper
• Interstitial Fluid Sphingosine-1-Phosphate in Murine Mammary Gland and Cancer and Human Breast Tissue and Cancer Determined by Novel Methods

  2016cites this paper
• Sphingosine 1-phosphate and sphingosine kinases in health and disease: Recent advances.

  2016cites this paper
• Sphingosine kinase 2 deficient mice exhibit reduced experimental autoimmune encephalomyelitis: Resistance to FTY720 but not ST-968 treatments.

  2016cites this paper
• Utility of Bifunctional N-Heterocyclic Phosphine (NHP)-Thioureas for Metal-Free Carbon-Phosphorus Bond Construction toward Regio- and Stereoselective Formation of Vinylphosphonates.

  2016cites this paper
• Addressing the Potential Role of Fingolimod in Cancer Therapy

  2016cites this paper
• The roles of sphingosine in calcium signaling and Niemann-Pick disease type C

  2016cites this paper
• A promising anti-cancer agent that functions as a dual target inhibitor of SphK1 and microtubule dynamics

  2016cites this paper
• FTY 720 ( Fingolimod ) attenuates basal and sphingosine-1-phosphate-evoked thyroid cancer cell invasion

  2016influential citation
• Aberrant expression of the S1P regulating enzymes, SPHK1 and SGPL1, contributes to a migratory phenotype in OSCC mediated through S1PR2

  2016cites this paper
• From Sphingosine Kinase to Dihydroceramide Desaturase: A Structure-Activity Relationship (SAR) Study of the Enzyme Inhibitory and Anticancer Activity of 4-((4-(4-Chlorophenyl)thiazol-2-yl)amino)phenol (SKI-II).

  2016cites this paper